Recombinant SARS-CoV-2 Spike protein, RBD (Receptor Binding Domain) encompassing amino acids 319-541. This protein corresponds to SARS-CoV-2 Variant B.1.1.7, originally discovered in the United Kingdom, and contains mutation N501Y. It also contains a C-terminal Avi-Tag and a C-terminal His-tag. The recombinant protein is>=90% pure following high affinity Ni-NTA purification. Constructs: Spike RBD (B.1.1.7) (SARS-CoV-2) (319-541-Avi-His)
Formulation
8 mM phosphate pH 7.4, 110 mM NaCl, 2.2 mM KCl, 20% glycerol